Page last updated: 2024-09-05

sorafenib and Idiopathic Pulmonary Fibrosis

sorafenib has been researched along with Idiopathic Pulmonary Fibrosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bai, J; Chen, YL; Ding, X; Gai, L; Li, HP; Xu, L; Xu, Q; Ye, XL; Zhang, L; Zhang, X; Zhang, YX1

Other Studies

1 other study(ies) available for sorafenib and Idiopathic Pulmonary Fibrosis

ArticleYear
Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation.
    Cell death & disease, 2013, Jun-13, Volume: 4

    Topics: Alveolar Epithelial Cells; Animals; Apoptosis; Bleomycin; Cell Line, Tumor; Cell Proliferation; Epithelial-Mesenchymal Transition; Extracellular Matrix; Female; Fibroblasts; HEK293 Cells; Humans; Idiopathic Pulmonary Fibrosis; Male; Mice; Mice, Inbred C57BL; Niacinamide; NIH 3T3 Cells; Phenylurea Compounds; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Sorafenib; Transforming Growth Factor beta1

2013